Sonus, FDA Agree To Terms For Tocosol Paclitaxel SPA July 11, 2005 By Aaron Lorenzo Sonus Pharmaceuticals Inc. is moving forward with pivotal development plans for its lead product, Tocosol Paclitaxel, after completing a special protocol assessment for a single Phase III trial. (BioWorld Today)Read More